CRIS Current Research Information System

PICCI, PIERO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.278
AS - Asia 5.372
EU - Europa 3.988
SA - Sud America 342
AF - Africa 311
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 16.304
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.210
VN - Vietnam 1.581
SG - Singapore 1.504
CN - Cina 1.191
GB - Regno Unito 946
IT - Italia 588
DE - Germania 583
SE - Svezia 522
HK - Hong Kong 430
FR - Francia 273
RU - Federazione Russa 269
BR - Brasile 247
IN - India 237
IE - Irlanda 169
UA - Ucraina 146
JP - Giappone 105
CH - Svizzera 103
ZA - Sudafrica 102
NL - Olanda 94
CI - Costa d'Avorio 90
KR - Corea 73
EE - Estonia 65
TG - Togo 58
BG - Bulgaria 52
JO - Giordania 52
FI - Finlandia 45
AR - Argentina 41
CA - Canada 36
BE - Belgio 35
PH - Filippine 30
TH - Thailandia 26
BD - Bangladesh 25
ID - Indonesia 23
PL - Polonia 22
ES - Italia 21
IQ - Iraq 19
SC - Seychelles 19
MX - Messico 18
TR - Turchia 16
EC - Ecuador 14
GR - Grecia 14
AT - Austria 13
TW - Taiwan 12
AU - Australia 11
CL - Cile 10
CO - Colombia 10
SA - Arabia Saudita 10
UZ - Uzbekistan 9
MA - Marocco 7
PK - Pakistan 7
EG - Egitto 6
PE - Perù 6
AL - Albania 5
ET - Etiopia 5
LB - Libano 5
LT - Lituania 5
NG - Nigeria 5
UY - Uruguay 5
VE - Venezuela 5
DZ - Algeria 4
IR - Iran 4
PY - Paraguay 4
CR - Costa Rica 3
GT - Guatemala 3
HR - Croazia 3
MY - Malesia 3
RO - Romania 3
TN - Tunisia 3
AM - Armenia 2
BY - Bielorussia 2
BZ - Belize 2
GH - Ghana 2
HU - Ungheria 2
KE - Kenya 2
NO - Norvegia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
CM - Camerun 1
DJ - Gibuti 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
MK - Macedonia 1
MU - Mauritius 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
Totale 16.302
Salva come PNG Salva come JPEG
Città #
Singapore 1.027
Southend 826
Ashburn 671
Fairfield 621
Chandler 520
San Jose 419
Hong Kong 415
Ho Chi Minh City 313
Woodbridge 309
Hanoi 304
Wilmington 293
Houston 281
Santa Clara 269
Seattle 266
Ann Arbor 263
Cambridge 238
Dong Ket 233
Princeton 229
Beijing 179
Dublin 169
Boardman 142
Hefei 126
Lauterbourg 111
Bern 92
Tokyo 91
Abidjan 90
Westminster 83
Nanjing 82
Jacksonville 78
Padova 77
Bologna 72
Berlin 68
Los Angeles 66
Turin 63
Seoul 59
Lomé 58
Amman 52
Sofia 48
Buffalo 47
Bremen 46
Haiphong 44
Saint Petersburg 44
San Diego 43
Frankfurt am Main 41
Da Nang 38
Hebei 38
Helsinki 38
New York 37
Redondo Beach 37
Jinan 36
Council Bluffs 35
Falls Church 35
Shenyang 35
Brussels 34
Guangzhou 32
Milan 32
Dallas 31
Changsha 30
Nanchang 30
São Paulo 29
Des Moines 26
Tianjin 23
London 22
Mülheim 22
Zhengzhou 21
Redmond 20
Falkenstein 19
Florence 19
Medford 19
Dearborn 18
Düsseldorf 18
Shanghai 17
Shenzhen 17
Amsterdam 16
Nuremberg 16
Olalla 16
Rome 16
Bengaluru 15
Hải Dương 15
Phoenix 15
Warsaw 15
Jiaxing 14
Chicago 13
Munich 13
Biên Hòa 12
Can Tho 12
Chengdu 12
Ningbo 12
Thái Nguyên 12
Brooklyn 11
Jakarta 11
Johannesburg 11
Redwood City 11
San Francisco 11
The Dalles 11
Toronto 11
Catanzaro 10
Haikou 10
Bangkok 9
Bühl 9
Totale 10.715
Salva come PNG Salva come JPEG
Nome #
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations 317
Excision repair cross-complementation group 1 protein expression predicts survival in patients with high-grade, non-metastatic osteosarcoma treated with neoadjuvant chemotherapy 247
Evaluation of the molecular mechanisms involved in the gain of function of a Li-Fraumeni TP53 mutation. 244
CIC-DUX4 fusion-positive round-cell sarcomas of soft tissue and bone: A single-institution morphological and molecular analysis of seven cases 226
A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy 226
Molecular mechanisms of CD99-induced caspase-independent cell death and cell-cell adhesion in Ewing's sarcoma cells: actin and zyxin as key intracellular mediators. 221
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: An Italian sarcoma group study 221
CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity. 218
Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1 212
CD99 Acts as an Oncosuppressor in Osteosarcoma. 211
Clinical outcome of central conventional chondrosarcoma. 206
Spontaneous healing of an osteochondroma fracture. 204
Insulin-like growth factor 2 mRNA-binding protein 3 is a novel post-transcriptional regulator of Ewing sarcoma malignancy 203
Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone 202
Osteosarcoma follow-up: chest X-ray or computed tomography? 199
Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long? 194
The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas 192
An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas. 191
Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation 191
CD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2. 190
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. 190
HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma 187
Biological indicators of prognosis in Ewing’s sarcoma: an emerging role for lectin galactoside-binding soluble 3 binding protein (LGALS3BP). 184
Bone marrow biopsy in the initial staging of Ewing sarcoma: Experience from a single institution 181
Ewing sarcoma in patients over 40 years of age: A prospective analysis of 31 patients treated at a single institution 180
Abstract 3201: Insulin-like growth factor 2 (IGF-2) mRNA binding protein 3 predicts poor prognosis and promotes cell proliferation in Ewing sarcoma 179
Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases 178
CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity 176
A simple prognostic scoring system for non metastatic osteosarcoma of the extremity 171
Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients 171
Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas 169
Small cell osteosarcoma: Clinicopathologic, immunohistochemical, and molecular analysis of 36 cases 168
Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug. 167
Whole lung irradiation after high‐dose busulfan/melphalan in ewing sarcoma with lung metastases: An Italian sarcoma group and associazione Italiana ematologia oncologia pediatrica joint study 165
Second malignancy in 597 patients with Ewing Sarcoma of Bone treated and a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999 162
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: A non-randomised phase 2 clinical trial 162
CIC-DUX4 Fusion-Positive Round Cell Sarcomas of Soft Tissue and Bone: Clinicopthologic and Molecular Analysis from a Single Institution 160
Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression 159
Angiosarcoma of bone: a retrospective study of the European Musculoskeletal Oncology Society (EMSOS) 158
Response to high-dose ifosfamide in patients with advanced/recurrent ewing sarcoma 157
Identification of common and distinctive mechanisms of resistance to different anti-IGF-IR agents in Ewing's sarcoma 157
NVE-BEZ235 as a new therapeutic option for sarcomas. 157
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2) 154
Feasibility of preoperative chemotherapy with or without radiation therapy in localized soft tissue sarcomas of limbs and superficial trunk in the Italian sarcoma group/grupo español de investigación en sarcomas randomized clinical trial: Three versus five cycles of full-dose epirubicin plus ifosfamide 153
Molecular diagnosis in ewing family tumors the rizzoli experience-222 consecutive cases in four years 152
Osteoblastoma-like osteosarcoma: high-grade or low-grade osteosarcoma? 152
Adjiuvant treatment of high-risk adult soft tissue sarcomas: a survey by the Italian Sarcoma Group 151
Osteosarcoma of the pelvis: A monoinstitutional experience in patients younger than 41 years 151
Osteosarcoma of the pelvis and sacrum: A retrospective analysis of 73 patients. 149
Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling. 147
Angiosarcoma of bone: A European Muscoloskeletal Oncology Society (EMSOS) multicenter, retrospective study 147
Preclinical in vivo study of new insulin-like growth factor-I receptor-specific inhibitor in Ewing’s sarcoma. 146
High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series 146
The natural history of advanced inoperable central chondrosarcoma 145
Neoadjuvant chemotherapy for osteosarcoma of the extremities in preadolescent patients: The rizzoli institute experience 144
Sarcomi delle parti molli. Tredici anni di esperienza dell'Istituto Ortopedico Rizzoli - Sarcomas of the soft tissues. Thirteen years of experience at the Rizzoli Orthopaedic Institute. 143
Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a post-hoc analysis 142
Primary Angiosarcoma of Bone: A Retrospective Analysis of 60 Patients From 2 Institutions 142
Targeting CD99 in association with doxorubicin: An effective combined treatment for Ewing’s sarcoma 142
Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Grouo/Scandinavian Sarcoma Group III protocol 141
Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: An Italian Sarcoma Group Trial ISG/OS-1 141
Pattern of relapse in 290 patients with nonmetastatic Ewing's sarcoma family tumors treated at a single institution with adjuvant chemotherapy between 1972 and 1999 140
Insulin-like growth factor binding protein 3 as an anti-cancer molecule in Ewing's sarcoma. 139
Treatment and prognosis for synchronous multifocal osteosarcoma in 42 patients 139
High-grade bone sarcomas with synchronous metastases in patients older than 40. Results of the European Bone over 40: Sarcoma Study (EURO.B.O.S.S.) 138
FDG PET/CT IN PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY FOR LOCALIZED BONE SARCOMAS 137
Genetic and Molecular alterations in rhabdomyosarcoma: mRNA overexpression of MCL1 and MAP2K4 genes. 135
Pediatric chondrosarcomas: a retrospective review of 17 cases 135
Molecular alterations of monophasic synovial sarcoma: Loss of chromosome 3p does not alter RASSF1 and MLH1 transcriptional activity 134
Advances in Bone Metastases Management 133
miR-494.3p expression in synovial sarcoma: Role of CXCR4 as a potential target gene 133
PD1 and PDL1 expression, tumoral microenvironment (TME) characterization and clinical implication in localized osteosarcoma 132
Fibrosarcomatous changes and expression of CD34+ and apolipoprotein-D in dermatofibrosarcoma protuberans. 132
Primary extraskeletal myxoid chondrosarcoma of bone: Report of three cases and review of the literature 132
Palliative therapy for osteosarcoma. 130
NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas 130
Osteosarcoma teleangectasico: analisi clinico-patologica di 87 casi 129
Epidemiology 127
Vincristine, doxorubicin, cyclophosfamide, actinomycin D, ifosfamide, and etoposide in adult and pediatric patients with nonmetastatic Ewing sarcoma. Final results of a monoinstitutional study 127
Denosumab in patients with aneurysmal bone cysts: A case series with preliminary results 127
Surgical treatment and results of 62 patients with epithelioid hemangioendothelioma of bone. 125
Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells 125
Inflammation and infiltration: can the radiologist draw a line? MRI versus CT to accurately assess medullary involvement in parosteal osteosarcoma 122
EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma 121
Platelet-derived growth factors enhance proliferation of human stromal stem cells 120
Parosteal osteosarcoma: a monocentric retrospective analysis of 195 patients 117
Primary metastatic Ewing's family tumors:results of the Italian Sarcoma Group And Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation. 115
How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation? 113
Anthracycline, gemcitabine, and pazopanib in epithelioid sarcoma a multi-institutional case series 112
Trabectedin for patients with advanced soft tissue sarcoma: A non-interventional, retrospective, multicenter study of the italian sarcoma group 112
Evoluzione dei trattamenti integrati nei sarcomi dei tessuti molli all'Istituto Ortopedico Rizzoli 111
Sacral Chordoma: Long-term outcome of a large series of patients surgically treated at two reference centers 111
Recovery of stromal stem cells in bone sarcoma patients after chemotherapy: Implication for cell-based therapy in bone defect reconstruction 111
Reconstruction in the treatment of pelvic chondrosarcoma. 110
Malignancy in Giant Cell Tumor of Bone: A Review of the Literature 109
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: Final results of a randomized trial from Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) sarcoma groups 107
Imaging of bone tumours for the musculoskeletal oncology surgeon. 104
Tenosynovial giant cell tumour/pigmented villonodular synovitis: Outcome of 294 patients before the era of kinase inhibitors. 100
Dedifferentiated chondrosarcoma: preliminary results from the European Bone over 40 sarcomas study, (EURO.B.O.S.S.) 99
Palliative treatment: selective arterial embolisation for bone metastases. 97
Totale 15.611
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.889
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.889
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021625 0 0 0 0 0 0 0 0 0 80 57 488
2021/20221.916 160 56 125 136 185 123 46 139 67 176 391 312
2022/20232.258 227 283 123 300 142 144 74 142 387 69 183 184
2023/2024479 23 107 41 37 22 75 40 40 14 26 23 31
2024/20252.212 106 354 191 135 388 99 132 77 19 169 76 466
2025/20265.051 480 568 435 386 576 304 502 310 1.147 343 0 0
Totale 16.582